Physician profile
Bruce B Becker
NPI 1376584433
$3,869.39
in general payments reported to CMS, 2019-2025
17 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $318 · 2021: $408 · 2022: $540 · 2023: $559 · 2024: $893 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,875.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $1,003.47 | 2021-2025 | Xeomin |
| Glaukos Corporation | $568.65 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Merz North America, INC. | $509.99 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $374.39 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $299.38 | 2019-2024 | |
| Horizon Therapeutics Plc | $260.04 | 2022-2023 | Tepezza |
| Amgen INC. | $167.12 | 2024-2025 | Tepezza |
| Shire North American Group INC | $137.73 | 2019 | |
| Ani Pharmaceuticals, INC. | $116.33 | 2025 | Purified Cortrophin Gel |
| Tarsus Pharmaceuticals, INC. | $114.33 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $107.13 | 2019 | |
| Harrow Eye, LLC | $56.76 | 2025 | Vevye |
| Bausch & Lomb Americas INC. | $46.60 | 2025 | Miebo |
| Oyster Point Pharma, INC. | $38.10 | 2025 | Tyrvaya |
| Novo Nordisk INC | $32.27 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $19.17 | 2024 | Tearcare System |
| Biotissue Holdings INC. | $17.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.